Fig. 2From: Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer(a) Overall survival and (b) Recurrence-free survival of patients with resected stage 1 NSCLC according to the NLR. The overall survival rate and the recurrence-free survival rate of patients with low NLRs was significantly higher than that in patients with intermediate and high NLRsBack to article page